You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Novellus on Monday said it is working with Tempus to accelerate patient enrollment for its BRAF inhibitor program.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.